Costco dips premarket; Bristol-Myers Squibb, Wynn Resorts rise

Investing.com -- US stock futures were broadly muted on Friday as investors awaited the release of a raft of economic data, including new consumer spending figures and the Federal Reserve's preferred gauge of inflation.

By 06:31 ET (10:31 GMT), the Dow futures contract was mostly unchanged, S&P 500 futures had shed 5 points or 0.1%, and Nasdaq 100 futures had edged down by 43 points or 0.2%.

Here are some of the biggest premarket US stock movers today:

Costco (NASDAQ:COST ) reported fiscal fourth-quarter revenue that fell short of analyst estimates, as a dip in spending on big-ticket items and lower gasoline prices weighed on the membership-only warehouse chain. Shares in the company dipped by 1.4% in premarket US trading in the wake of the report. They have gained roughly 38.5% so far this year.

Bristol-Myers Squibb (NYSE:BMY ) shares jumped after US regulators approved the first new type of schizophrenia drug in decades. The labelling information of the treatment, Cobenfy, does not include a warning about the higher risk of mortality among some elderly patients, granting further support to the stock.

Cassava Sciences (NASDAQ:SAVA ) shares slumped after the drugmaker and two of its former executives agreed to pay more than $40 million to settle federal claims that they had issued misleading statements around the outcome of an Alzheimer's drug trial.

Dollar General (NYSE:DG ) shares slid after analysts at Citi flagged market share gains made by rival Walmart (NYSE:WMT ) would pressure the firm.

HP Inc. (NYSE:HPQ ) shares fell after analysts at Bank of America downgraded their rating of the company to "Neutral" from "Buy" on concerns over its print division.

Online-learning group Udemy (NASDAQ:UDMY ) saw its stock price slip after Morgan Stanley lowered its rating to "Underweight" and warned of weak demand.

Wynn Resorts (NASDAQ:WYNN ) shares rose after analysts at Morgan Stanley upgraded their outlook for the company to "Overweight", arguing that it has become more attractive thanks to a lower valuation and opportunities in the United Arab Emirates.

Establishment Labs (NASDAQ:ESTA ) shares surged after the medical technology company said it had received US approval for its Motiva breast implants.

Source: Investing.com